JULIUS KNOWLES

Julius Knowles is a distinguished Partner at Mass General Brigham Ventures, a leading venture capital firm dedicated to investing in groundbreaking healthcare and life sciences companies. In his pivotal role, Julius is instrumental in sourcing, evaluating, and leading investments in early to growth-stage enterprises that align with Mass General Brigham's mission to transform medicine and improve patient lives.

His investment focus areas are broad yet deeply specialized, encompassing the most dynamic sectors within healthcare. Julius actively seeks opportunities in biotechnology, particularly novel therapeutics and diagnostics that address unmet medical needs. He also has a keen interest in medical devices, especially those offering minimally invasive solutions or enhanced diagnostic capabilities. Digital health and healthcare IT are significant areas of exploration for Julius, as he believes in the power of technology to optimize clinical workflows, enhance patient engagement, and deliver more personalized care. His portfolio often includes companies leveraging artificial intelligence, machine learning, and data analytics to drive innovation in healthcare.

Before joining Mass General Brigham Ventures, Julius built a robust career foundation that uniquely positioned him for success in healthcare venture capital. He previously held a senior role at a prominent life sciences investment bank, where he advised numerous biotech and medtech companies on strategic transactions and capital raises. Prior to that, Julius gained invaluable operational experience within a fast-growing digital health startup, giving him firsthand insight into the challenges and opportunities of scaling innovative healthcare solutions. His early career included a stint in biomedical research, providing him with a deep scientific understanding that informs his investment decisions.

While specific investment details are often confidential, Julius Knowles has been instrumental in backing several promising ventures. These include companies developing next-generation gene therapies for rare diseases, AI-powered platforms for early disease detection, and novel surgical robotics designed to improve precision and recovery times. His commitment to fostering innovation and supporting visionary entrepreneurs underscores his impact at Mass General Brigham Ventures, driving forward solutions that promise a healthier future.

Julius Knowles is recognized for his strategic acumen, deep industry knowledge, and dedication to collaborating with founders to build successful, impactful companies. His work at Mass General Brigham Ventures continues to shape the landscape of healthcare innovation, bringing vital capital and expertise to the most promising advancements in medicine.